These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Branco LM; Grove JN; Boisen ML; Shaffer JG; Goba A; Fullah M; Momoh M; Grant DS; Garry RF Virol J; 2011 Oct; 8():478. PubMed ID: 22023795 [TBL] [Abstract][Full Text] [Related]
4. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. Branco LM; Boisen ML; Andersen KG; Grove JN; Moses LM; Muncy IJ; Henderson LA; Schieffellin JS; Robinson JE; Bangura JJ; Grant DS; Raabe VN; Fonnie M; Zaitsev EM; Sabeti PC; Garry RF Virol J; 2011 Aug; 8():404. PubMed ID: 21843352 [TBL] [Abstract][Full Text] [Related]
5. Health seeking behavior after the 2013-16 Ebola epidemic: Lassa fever as a metric of persistent changes in Kenema District, Sierra Leone. Koch MR; Kanneh L; Wise PH; Kurina LM; Alhasan F; Garry RF; Schieffelin JS; Shaffer JG; Grant DS PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009576. PubMed ID: 34260615 [TBL] [Abstract][Full Text] [Related]
6. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues. Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220 [TBL] [Abstract][Full Text] [Related]
7. Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone. Dahmane A; van Griensven J; Van Herp M; Van den Bergh R; Nzomukunda Y; Prior J; Alders P; Jambai A; Zachariah R Trans R Soc Trop Med Hyg; 2014 Mar; 108(3):126-32. PubMed ID: 24535150 [TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study. Grant DS; Engel EJ; Roberts Yerkes N; Kanneh L; Koninga J; Gbakie MA; Alhasan F; Kanneh FB; Kanneh IM; Kamara FK; Momoh M; Yillah MS; Foday M; Okoli A; Zeoli A; Weldon C; Bishop CM; Zheng C; Hartnett J; Chao K; Shore K; Melnik LI; Mucci M; Bond NG; Doyle P; Yenni R; Podgorski R; Ficenec SC; Moses L; Shaffer JG; Garry RF; Schieffelin JS PLoS Negl Trop Dis; 2023 Feb; 17(2):e0010938. PubMed ID: 36758101 [TBL] [Abstract][Full Text] [Related]
12. Lassa fever in children in Sierra Leone, West Africa. Webb PA; McCormick JB; King IJ; Bosman I; Johnson KM; Elliott LH; Kono GK; O'Sullivan R Trans R Soc Trop Med Hyg; 1986; 80(4):577-82. PubMed ID: 3810792 [TBL] [Abstract][Full Text] [Related]
13. A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges. Shaffer JG; Schieffelin JS; Gbakie M; Alhasan F; Roberts NB; Goba A; Randazzo J; Momoh M; Moon TD; Kanneh L; Levy DC; Podgorski RM; Hartnett JN; Boisen ML; Branco LM; Samuels R; Grant DS; Garry RF; PLoS One; 2019; 14(3):e0214284. PubMed ID: 30921383 [TBL] [Abstract][Full Text] [Related]
14. Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers. Gale TV; Horton TM; Grant DS; Garry RF PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005943. PubMed ID: 28922385 [TBL] [Abstract][Full Text] [Related]
15. Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever. Boisen ML; Hartnett JN; Shaffer JG; Goba A; Momoh M; Sandi JD; Fullah M; Nelson DKS; Bush DJ; Rowland MM; Heinrich ML; Koval AP; Cross RW; Barnes KG; Lachenauer AE; Lin AE; Nekoui M; Kotliar D; Winnicki SM; Siddle KJ; Gbakie M; Fonnie M; Koroma VJ; Kanneh L; Kulakosky PC; Hastie KM; Wilson RB; Andersen KG; Folarin OO; Happi CT; Sabeti PC; Geisbert TW; Saphire EO; Khan SH; Grant DS; Schieffelin JS; Branco LM; Garry RF Sci Rep; 2018 Apr; 8(1):5939. PubMed ID: 29651117 [TBL] [Abstract][Full Text] [Related]
16. Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak. Boisen ML; Schieffelin JS; Goba A; Oottamasathien D; Jones AB; Shaffer JG; Hastie KM; Hartnett JN; Momoh M; Fullah M; Gabiki M; Safa S; Zandonatti M; Fusco M; Bornholdt Z; Abelson D; Gire SK; Andersen KG; Tariyal R; Stremlau M; Cross RW; Geisbert JB; Pitts KR; Geisbert TW; Kulakoski P; Wilson RB; Henderson L; Sabeti PC; Grant DS; Garry RF; Saphire EO; Branco LM; Khan SH; Viral Immunol; 2015 Feb; 28(1):19-31. PubMed ID: 25531344 [TBL] [Abstract][Full Text] [Related]
17. No evidence for increased risk of Lassa fever infection in hospital staff. Helmick CG; Webb PA; Scribner CL; Krebs JW; McCormick JB Lancet; 1986 Nov; 2(8517):1202-5. PubMed ID: 2877335 [TBL] [Abstract][Full Text] [Related]
18. Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. Grove JN; Branco LM; Boisen ML; Muncy IJ; Henderson LA; Schieffellin JS; Robinson JE; Bangura JJ; Fonnie M; Schoepp RJ; Hensley LE; Seisay A; Fair JN; Garry RF Virol J; 2011 Jun; 8():314. PubMed ID: 21689444 [TBL] [Abstract][Full Text] [Related]
19. Genetic basis underlying Lassa fever endemics in the Mano River region, West Africa. Li Y Virology; 2023 Feb; 579():128-136. PubMed ID: 36669329 [TBL] [Abstract][Full Text] [Related]
20. Beyond Lassa Fever: Systemic and structural barriers to disease detection and response in Sierra Leone. Rohan H PLoS Negl Trop Dis; 2022 May; 16(5):e0010423. PubMed ID: 35587495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]